Congenital Heart Malformations Clinical Trial
Official title:
Evolution of Two Cohorts of Children (Univentricular and Bi-ventricular Heart) After Strapping of the Pulmonary Artery
NCT number | NCT03047343 |
Other study ID # | CHUB-strapping |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | March 1, 2017 |
Est. completion date | May 29, 2018 |
Verified date | May 2018 |
Source | Brugmann University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Pulmonary artery strapping is a surgical technique aimed at providing a palliative treatment
to newborns suffering from congenital heart defects, characterized by an increase in blood
flow and pulmonary blood pressure.
The intervention consists of placing a band around the pulmonary artery. This band causes an
artificial stenosis, therefore inducing a reduction of the pulmonary arterial pressure. It
acts as a first step, preparing the ground for a future definitive repair intervention.
It is mainly used in the context of septal defects, atrio-ventricular canal defects or
uni-ventricular hearts.
The complications linked to strapping include, among others, the erosion of the band in the
artery lumen, its migration and the obstruction of the pulmonary artery, a pulmonary valvular
insufficiency, the obstruction of the coronary artery and an ineffective strapping.
The early mortality rate of pulmonary artery strapping after 1980 varies between 1.8% and
13.6%, while strapping readjustment rates oscillate around 20%. It is assumed that the
mortality is linked to the nature of the cardial malformation (uni-ventricular or
bi-ventricular) rather than the procedure itself.
This retrospective study aims to evaluate the intra-hospital and extra-hospital mortality
rate of pulmonary artery strapping, as well as the readjustment rate within two groups of
patients: those benefiting from an uni-ventricular cardiac reparation and those benefiting
from a bi-ventricular cardiac reparation. The aim is to determine the short term mortality
rate of the intervention and the incidence of complications within the hospital, within the
two groups.
Status | Completed |
Enrollment | 79 |
Est. completion date | May 29, 2018 |
Est. primary completion date | May 29, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - All patients treated with pulmonary artery strapping between 2005 and 2016 at the Queen Fabiola Children Hospital Exclusion Criteria: - Outdated indications |
Country | Name | City | State |
---|---|---|---|
Belgium | HUDERF | Brussels |
Lead Sponsor | Collaborator |
---|---|
Pierre Wauthy |
Belgium,
Brooks A, Geldenhuys A, Zuhlke L, Human P, Zilla P. Pulmonary artery banding: still a valuable option in developing countries? Eur J Cardiothorac Surg. 2012 Feb;41(2):272-6. doi: 10.1016/j.ejcts.2011.05.053. Epub 2011 Dec 12. — View Citation
Horowitz MD, Culpepper WS 3rd, Williams LC 3rd, Sundgaard-Riise K, Ochsner JL. Pulmonary artery banding: analysis of a 25-year experience. Ann Thorac Surg. 1989 Sep;48(3):444-50. — View Citation
Pinho P, Von Oppell UO, Brink J, Hewitson J. Pulmonary artery banding: adequacy and long-term outcome. Eur J Cardiothorac Surg. 1997 Jan;11(1):105-11. — View Citation
Takayama H, Sekiguchi A, Chikada M, Noma M, Ishizawa A, Takamoto S. Mortality of pulmonary artery banding in the current era: recent mortality of PA banding. Ann Thorac Surg. 2002 Oct;74(4):1219-23; discussion 1223-4. — View Citation
Valente AS, Mesquita F, Mejia JA, Maia IC, Maior MS, Branco KC, Pinto VC Jr, Carvalho W Jr. Pulmonary artery banding: a simple procedure? A critical analysis at a tertiary center. Rev Bras Cir Cardiovasc. 2009 Jul-Sep;24(3):327-33. English, Portuguese. — View Citation
Yoshimura N, Yamaguchi M, Oka S, Yoshida M, Murakami H. Pulmonary artery banding still has an important role in the treatment of congenital heart disease. Ann Thorac Surg. 2005 Apr;79(4):1463; author reply 1463-4. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Date of birth | Date of birth of the patient | 12 years | |
Primary | Sex | Sex of the patient | 12 years | |
Primary | Weight | Weight of the patient at the time of the intervention | 12 years | |
Primary | Exact diagnosis | Exact diagnosis at the time of the intervention | 12 years | |
Primary | Exact date of intervention | Exact calender date of intervention | 12 years | |
Primary | Total number of interventions | Total number of interventions | 12 years | |
Primary | SpO2 | pre-surgery oxygen saturation | 12 years | |
Primary | Date of death | If applicable, date of death of the patient | 12 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05101746 -
Nitric Oxide Effect on Brain and Kidney in Pediatric Patients Undergoing Cardiopulmonary Bypass
|
Phase 2/Phase 3 |